The results of the MLB coronavirus antibody study are in

YANICK FOLLY/AFP via Getty Images

Last month, it was announced that 10,000 employees employed by 26 of Major League Baseball’s 30 teams would be taking part in a coronavirus (COVID-19) study. The subjects had their blood drawn via pinprick, which was then studied for the presence of the lgM and lgG antibodies.

The results are back, ESPN’s Jeff Passan reports. 5,754 tests were returned, including 5,603 with completed surveys. 0.7 of the MLB employee population tested positive for COVID antibodies, lower than the results from similar studies. 70 percent of those who tested positive for the antibodies were asymptomatic.

Dr. Jay Bhattacharya, a professor of medicine at the University of Stanford which ran the study, said, “I was expecting a large number. It shows the value of doing the science as opposed to guessing.”

As Passan notes, the MLB employee population doesn’t reflect the U.S. population at large. Men made up 60 percent of the MLB employee population and white people comprised 80 percent. Furthermore, as most of the employees’ jobs could be classified as “white collar,” there is a socioeconomic factor to consider as well.

As mentioned last month, MLB did not volunteer for the study out of a desire to get the 2020 season started. MLB did not pay to join the study and the subjects’ identifying information was removed.